PURLs

Time to stop glucosamine and chondroitin for knee OA?

Author and Disclosure Information

 

References

CHALLENGES TO IMPLEMENTATION

An all-too-common product presents challenges

CS/GC is available over the counter and advertised directly to consumers. With this medication so readily available, identifying patients who are taking the supplement and encouraging discontinuation can be a challenge.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Pages

Copyright © 2018. The Family Physicians Inquiries Network. All rights reserved.

Online-Only Materials

AttachmentSize
PDF icon jfp06709566_methdology.pdf366.59 KB

Recommended Reading

Painful blisters on fingertips and toes
MDedge Family Medicine
Opioid use has not declined meaningfully
MDedge Family Medicine
Patients with chronic pain feel caught in an opioid-prescribing debate
MDedge Family Medicine
What to expect from next-gen CGRP inhibitors for migraine, cluster headache
MDedge Family Medicine
Compounded topicals flagged on fears of Medicare fraud, risk
MDedge Family Medicine
Concurrent stimulant and opioid use ‘common’ in adult ADHD
MDedge Family Medicine
Treating sleep disorders in chronic opioid users
MDedge Family Medicine
Migraine takes toll on intimate relationships
MDedge Family Medicine
Prescription opioid epidemic hits migraine patients hard
MDedge Family Medicine
Mindfulness training for migraine just beginning to gather steam
MDedge Family Medicine